John Buran, CEO of Flushing Financial Corporation, sits down with InvestmentNews anchor Gregg Greenberg to explain how higher-for-longer interest rates and commercial real estate worries are impacting regional banks.
Ed Slott, author of 'The Retirement Savings Time Bomb Ticks Louder', sits down with InvestmentNews anchor Gregg Greenberg to explain how to avoid unnecessary tax landmines and secure your retirement accounts.
Recognizing the leading finance firms across the US who are attracting advisors with their range of services and outstanding expertise.
Gene Goldman, chief investment officer at Cetera, sits down with InvestmentNews anchor Gregg Greenberg to explain why he believes investors should look to small-caps and value stocks ahead of the 3 Federal Reserve rate cuts he sees in 2024.
Kevin Mahn, president of Hennion & Walsh, sits down with InvestmentNews anchor Gregg Greenberg to explain why he believes investors should be cautious this summer as the bull market may be priced to perfection.
Jim Caron, portfolio solutions group CIO at Morgan Stanley Investment Management, sits down with InvestmentNews anchor Gregg Greenberg to explain why he believes US stocks may suffer a setback before year-end and Japanese equities still offer upside.
Dan Fletcher, senior portfolio manager at DWS Group, sits down with InvestmentNews anchor Gregg Greenberg to discuss the risks associated with China when investing in technology and auto stocks.
Daniel Gourvitch, president of Mercer Advisors, sits down with InvestmentNews anchor Gregg Greenberg to discuss his approach to AI, the 'RIA of the future,' and what it takes to compete in today's wealth management industry.
Robert Schein, chief investment officer at Blanke Schein, sits down with InvestmentNews anchor Gregg Greenberg to discuss how financial advisors should approach and educate clients going through a divorce.
Mike Rode, senior investment director at American Century Investments, sits down with InvestmentNews anchor Gregg Greenberg to explain why small-caps are set to outperform due to the rise of reshoring, new IPOs and biotechs.
